TLT advises diagnostic imaging company on acquisition of Burgess Diagnostics

National law firm TLT has advised Medneo UK Limited, one of the UK's leading diagnostic imaging providers, on its acquisition of Burgess Diagnostics. 

Burgess Diagnostics is a leading provider of mobile MRI and CT imaging services to the veterinary sector across the UK and Ireland and the acquisition represents Medneo's first move into veterinary imaging and the latest step in its growth strategy.  

The transaction expands Medneo's capabilities into the growing veterinary imaging market, broadening its service offering and specialist expertise while strengthening its position in the wider diagnostic imaging sector. 

It is also the latest in a series of recent acquisitions that TLT has advised the company on, following the acquisitions of the Fairford Medical fleet in 2025 and the acquisition of Ramsay Diagnostics UK mobile MRI and CT fleet in July 2026.  

TLT acted as lead legal adviser to Medneo on all corporate aspects of the acquisition, including transaction structuring, legal due diligence, negotiation of the share purchase agreement and supporting the client through signing and completion. 

The multidisciplinary TLT team was led by Corporate Partner Elizabeth Delaney, with support from Managing Associate Seraphina Willkins-Tolliday. Further cross practice support was provided by the firm's Real Estate; Tax; Employment; Banking; Regulatory; Commercial; and Data and IP teams.  

The transaction also highlights the strength of TLT's Manchester corporate team, working alongside specialists from across the firm to deliver seamless support on a complex strategic acquisition. 

Katy Lineker, CFO at Medneo UK Limited, said: "It has been a pleasure working with the TLT team on this transaction. Their advice has been pragmatic and commercially focused throughout, and they have worked closely with us to navigate the complexities of the deal and achieve a successful outcome. We really value the relationship we have built with the team and look forward to continuing to work together as Medneo progresses its growth strategy." 

Elizabeth Delaney, Partner commented: "We are delighted to have supported Medneo on another important strategic acquisition and to continue building on our wider relationship, with our corporate team having advised on the acquisition of the Fairford Medical fleet in 2025 and on the purchase of the Ramsay Diagnostics UK mobile MRI and CT fleet, as well as entry into long term partnership arrangements, earlier this year. This transaction is particularly interesting as it marks Medneo's entry into the veterinary imaging sector, broadening its service offering and creating further opportunities for growth. We look forward to continuing to work with Medneo as it delivers on its long-term growth strategy. 

 "This transaction reflects continued consolidation across the healthcare and diagnostic imaging markets, with businesses pursuing strategic acquisitions to access new capabilities, adjacent service lines and growing specialist sectors."